Anti-TNF therapy restores the hypothalamic-pituitary-adrenal axis: Annals of the New York Academy of Sciences

Fabiola Atzeni, Rainer H. Straub, Maurizio Cutolo, Piercarlo Sarzi-Puttini

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Tumor necrosis factor (TNF) inhibitors are associated with greater improvements in the symptoms and signs of rheumatoid arthritis (RA) and, more importantly, a lower risk of joint damage. TNF is an important mediator of the alterations in neuroendocrine axes characterizing RA. Long-term therapy with anti-TNF agents sensitizes the pituitary gland and improves adrenal androgen secretion, thus stimulating an alternative form of anti-inflammatory action.

Original languageEnglish
Title of host publicationAnnals of the New York Academy of Sciences
Pages179-181
Number of pages3
Volume1193
DOIs
Publication statusPublished - Apr 2010

Publication series

NameAnnals of the New York Academy of Sciences
Volume1193
ISSN (Print)00778923
ISSN (Electronic)17496632

    Fingerprint

Keywords

  • Cortisol
  • Hormones
  • Rheumatoid arthritis
  • TNF inhibitors

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Atzeni, F., Straub, R. H., Cutolo, M., & Sarzi-Puttini, P. (2010). Anti-TNF therapy restores the hypothalamic-pituitary-adrenal axis: Annals of the New York Academy of Sciences. In Annals of the New York Academy of Sciences (Vol. 1193, pp. 179-181). (Annals of the New York Academy of Sciences; Vol. 1193). https://doi.org/10.1111/j.1749-6632.2009.05366.x